Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iseman, M. D.
Right arrow Articles by Madsen, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iseman, M. D.
Right arrow Articles by Madsen, L. A.

Chest, Vol 100, 124-127, Copyright © 1991 by American College of Chest Physicians

ARTICLES

Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance

MD Iseman and LA Madsen
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver.

We treated five patients with a past history of tuberculous pleural infection that led to chronic, quiescent, loculated empyema. Reactivation of TB was associated with formation of BPF and recovery of drug-susceptible Mycobacterium tuberculosis from sputum. All patients had recurrence of positive sputum cultures that yielded tubercle bacilli resistant to drugs they were receiving. The lungs demonstrated gross thickening with calcification of both visceral and parietal pleura. Two patients underwent retreatment chemotherapy followed by decortication-empyemectomy and lung resection surgery; both are now culture-negative for TB. One patient received retreatment chemotherapy but refused surgery; he remains clinically stable with negative sputum cultures. Two other patients' organisms became drug-resistant and they remain sputum-culture positive. We believe that thick, calcified pleural walls limit penetration of drugs into the infected empyema space, resulting in suboptimal drug concentrations and drug resistance. Intensified chemotherapy and surgical intervention should be considered in these cases.


This article has been cited by other articles:


Home page
 ThoraxHome page
R van Altena, D van Soolingen, T S van der Werf, M C Ruddy, M D Yates, F A Drobniewski, A P Davies, Y Drabu, B Patel, S Yates, et al.
Isoniazid resistant TB and non-compliance
Thorax, December 1, 2004; 59(12): 1098 - 1099.
[Full Text] [PDF]

Home page
 ThoraxHome page
R Golpe, A Mateos, N Kunichika, and H Kunichika
Rifampicin induced pneumonitis or bronchogenic spread of tuberculous empyema through a bronchopleural fistula?
Thorax, October 1, 2003; 58(10): 910 - 910.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. H. Gillespie
Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective
Antimicrob. Agents Chemother., February 1, 2002; 46(2): 267 - 274.
[Full Text] [PDF]

Home page
 ChestHome page
A. Schaeffer-Pautz, L. F. Laos, D. P. Sorresso, and J. D. Cury
A Chest Wall Mass in a 73-Year-Old Man
Chest, December 1, 2001; 120(6): 2051 - 2052.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American College of Chest Physicians.